ALDX
Aldeyra Therapeutics, Inc.
1.40$
+0.7%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
Aldeyra Therapeutics, Inc. (ALDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.8 | -9.3 | -15 | -19 | -30 | -45 | -37 | -43 | -57 | -30 | -43 | -33 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | |
| 2.0 | 2.2 | 2.8 | 2.7 | 4.1 | 8.1 | 7.1 | 7.1 | 8.3 | 5.8 | 8.0 | 6.1 | |
| 2.0 | 2.2 | 2.8 | 2.7 | 4.1 | 13 | 8.4 | 7.1 | 8.3 | – | – | – | |
| 0.5 | 0.5 | 0.5 | 0.2 | 5.0 | 2.7 | -8.8 | 7.4 | -3.4 | 0.9 | 5.9 | -5.2 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | -13 | -0.2 | -10 | -23 | 18 | 29 | 0.0 | -30 | 30 | -45 | 48 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 10 | 29 | 13 | 38 | 82 | 9.2 | 42 | 194 | 1.2 | -0.5 | – | – | |
| – | -1.4 | -1.4 | -1.4 | -1.4 | 14 | – | – | 0.0 | -1.0 | -0.3 | 0.0 | |
| 10 | 28 | 13 | 37 | 81 | 24 | 42 | 194 | 1.2 | -1.3 | -0.2 | 1.1 | |
| 5.3 | 6.1 | -2.6 | 8.0 | 27 | -2.9 | 33 | 152 | -85 | -1.6 | -88 | 16 | |
| -4.8 | -9.4 | -15 | -19 | -30 | -45 | -37 | -43 | -57 | -30 | -43 | -33 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.